Prostate Cancer Medicine Market Report

China Prostate Cancer Medicine Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 25, 2022
  • PAGES：135
  • REPORT CODE：GMM1172078
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Prostate Cancer Medicine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Prostate Cancer Medicine market. Detailed analysis of key players, along with key growth strategies adopted by Prostate Cancer Medicine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Astellas Pharma Inc

    • Roche Holding AG

    • Johnson & Johnson

    • Pfizer Inc

    • Bristol Myers-Squibb

    • Abbott Laboratories

    • AstraZeneca plc

    • Teva Pharmaceuticals Industries Ltd

    • Active Biotech

    • Bayer AG

    By Type:

    • LHRH Antagonists

    • LHRH Analogs

    • Antiandrogens

    • Pipeline Drugs for Hormonal Therapy

    By End-User:

    • Hospitals

    • Clinics

    • Other

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Prostate Cancer Medicine Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Prostate Cancer Medicine Market Size and Growth Rate of LHRH Antagonists from 2016 to 2027

    • 1.3.2 China Prostate Cancer Medicine Market Size and Growth Rate of LHRH Analogs from 2016 to 2027

    • 1.3.3 China Prostate Cancer Medicine Market Size and Growth Rate of Antiandrogens from 2016 to 2027

    • 1.3.4 China Prostate Cancer Medicine Market Size and Growth Rate of Pipeline Drugs for Hormonal Therapy from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Prostate Cancer Medicine Market Size and Growth Rate of Hospitals from 2016 to 2027

    • 1.4.2 China Prostate Cancer Medicine Market Size and Growth Rate of Clinics from 2016 to 2027

    • 1.4.3 China Prostate Cancer Medicine Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Prostate Cancer Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Prostate Cancer Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Prostate Cancer Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Prostate Cancer Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Prostate Cancer Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Prostate Cancer Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Prostate Cancer Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Prostate Cancer Medicine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Prostate Cancer Medicine by Major Types

    • 3.4.1 Market Size and Growth Rate of LHRH Antagonists

    • 3.4.2 Market Size and Growth Rate of LHRH Analogs

    • 3.4.3 Market Size and Growth Rate of Antiandrogens

    • 3.4.4 Market Size and Growth Rate of Pipeline Drugs for Hormonal Therapy

    4 Segmentation of Prostate Cancer Medicine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Prostate Cancer Medicine by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Prostate Cancer Medicine in Hospitals

    • 4.4.2 Market Size and Growth Rate of Prostate Cancer Medicine in Clinics

    • 4.4.3 Market Size and Growth Rate of Prostate Cancer Medicine in Other

    5 Market Analysis by Regions

    • 5.1 China Prostate Cancer Medicine Production Analysis by Regions

    • 5.2 China Prostate Cancer Medicine Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Prostate Cancer Medicine Landscape Analysis

    • 6.1 North China Prostate Cancer Medicine Landscape Analysis by Major Types

    • 6.2 North China Prostate Cancer Medicine Landscape Analysis by Major End-Users

    7 Central China Prostate Cancer Medicine Landscape Analysis

    • 7.1 Central China Prostate Cancer Medicine Landscape Analysis by Major Types

    • 7.2 Central China Prostate Cancer Medicine Landscape Analysis by Major End-Users

    8 South China Prostate Cancer Medicine Landscape Analysis

    • 8.1 South China Prostate Cancer Medicine Landscape Analysis by Major Types

    • 8.2 South China Prostate Cancer Medicine Landscape Analysis by Major End-Users

    9 East China Prostate Cancer Medicine Landscape Analysis

    • 9.1 East China Prostate Cancer Medicine Landscape Analysis by Major Types

    • 9.2 East China Prostate Cancer Medicine Landscape Analysis by Major End-Users

    10 Northeast China Prostate Cancer Medicine Landscape Analysis

    • 10.1 Northeast China Prostate Cancer Medicine Landscape Analysis by Major Types

    • 10.2 Northeast China Prostate Cancer Medicine Landscape Analysis by Major End-Users

    11 Southwest China Prostate Cancer Medicine Landscape Analysis

    • 11.1 Southwest China Prostate Cancer Medicine Landscape Analysis by Major Types

    • 11.2 Southwest China Prostate Cancer Medicine Landscape Analysis by Major End-Users

    12 Northwest China Prostate Cancer Medicine Landscape Analysis

    • 12.1 Northwest China Prostate Cancer Medicine Landscape Analysis by Major Types

    • 12.2 Northwest China Prostate Cancer Medicine Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Astellas Pharma Inc

      • 13.1.1 Astellas Pharma Inc Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Roche Holding AG

      • 13.2.1 Roche Holding AG Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Johnson & Johnson

      • 13.3.1 Johnson & Johnson Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Pfizer Inc

      • 13.4.1 Pfizer Inc Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Bristol Myers-Squibb

      • 13.5.1 Bristol Myers-Squibb Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Abbott Laboratories

      • 13.6.1 Abbott Laboratories Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 AstraZeneca plc

      • 13.7.1 AstraZeneca plc Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Teva Pharmaceuticals Industries Ltd

      • 13.8.1 Teva Pharmaceuticals Industries Ltd Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Active Biotech

      • 13.9.1 Active Biotech Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Bayer AG

      • 13.10.1 Bayer AG Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Prostate Cancer Medicine Market Size and Growth Rate of LHRH Antagonists from 2016 to 2027

    • Figure China Prostate Cancer Medicine Market Size and Growth Rate of LHRH Analogs from 2016 to 2027

    • Figure China Prostate Cancer Medicine Market Size and Growth Rate of Antiandrogens from 2016 to 2027

    • Figure China Prostate Cancer Medicine Market Size and Growth Rate of Pipeline Drugs for Hormonal Therapy from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Prostate Cancer Medicine Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure China Prostate Cancer Medicine Market Size and Growth Rate of Clinics from 2016 to 2027

    • Figure China Prostate Cancer Medicine Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Prostate Cancer Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Prostate Cancer Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Prostate Cancer Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Prostate Cancer Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Prostate Cancer Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Prostate Cancer Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Prostate Cancer Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Prostate Cancer Medicine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Prostate Cancer Medicine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Prostate Cancer Medicine by Different Types from 2016 to 2027

    • Table Consumption Share of Prostate Cancer Medicine by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of LHRH Antagonists

    • Figure Market Size and Growth Rate of LHRH Analogs

    • Figure Market Size and Growth Rate of Antiandrogens

    • Figure Market Size and Growth Rate of Pipeline Drugs for Hormonal Therapy

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Prostate Cancer Medicine by Different End-Users from 2016 to 2027

    • Table Consumption Share of Prostate Cancer Medicine by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Other

    • Table China Prostate Cancer Medicine Production by Regions

    • Table China Prostate Cancer Medicine Production Share by Regions

    • Figure China Prostate Cancer Medicine Production Share by Regions in 2016

    • Figure China Prostate Cancer Medicine Production Share by Regions in 2021

    • Figure China Prostate Cancer Medicine Production Share by Regions in 2027

    • Table China Prostate Cancer Medicine Consumption by Regions

    • Table China Prostate Cancer Medicine Consumption Share by Regions

    • Figure China Prostate Cancer Medicine Consumption Share by Regions in 2016

    • Figure China Prostate Cancer Medicine Consumption Share by Regions in 2021

    • Figure China Prostate Cancer Medicine Consumption Share by Regions in 2027

    • Table North China Prostate Cancer Medicine Consumption by Types from 2016 to 2027

    • Table North China Prostate Cancer Medicine Consumption Share by Types from 2016 to 2027

    • Figure North China Prostate Cancer Medicine Consumption Share by Types in 2016

    • Figure North China Prostate Cancer Medicine Consumption Share by Types in 2021

    • Figure North China Prostate Cancer Medicine Consumption Share by Types in 2027

    • Table North China Prostate Cancer Medicine Consumption by End-Users from 2016 to 2027

    • Table North China Prostate Cancer Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure North China Prostate Cancer Medicine Consumption Share by End-Users in 2016

    • Figure North China Prostate Cancer Medicine Consumption Share by End-Users in 2021

    • Figure North China Prostate Cancer Medicine Consumption Share by End-Users in 2027

    • Table Central China Prostate Cancer Medicine Consumption by Types from 2016 to 2027

    • Table Central China Prostate Cancer Medicine Consumption Share by Types from 2016 to 2027

    • Figure Central China Prostate Cancer Medicine Consumption Share by Types in 2016

    • Figure Central China Prostate Cancer Medicine Consumption Share by Types in 2021

    • Figure Central China Prostate Cancer Medicine Consumption Share by Types in 2027

    • Table Central China Prostate Cancer Medicine Consumption by End-Users from 2016 to 2027

    • Table Central China Prostate Cancer Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Prostate Cancer Medicine Consumption Share by End-Users in 2016

    • Figure Central China Prostate Cancer Medicine Consumption Share by End-Users in 2021

    • Figure Central China Prostate Cancer Medicine Consumption Share by End-Users in 2027

    • Table South China Prostate Cancer Medicine Consumption by Types from 2016 to 2027

    • Table South China Prostate Cancer Medicine Consumption Share by Types from 2016 to 2027

    • Figure South China Prostate Cancer Medicine Consumption Share by Types in 2016

    • Figure South China Prostate Cancer Medicine Consumption Share by Types in 2021

    • Figure South China Prostate Cancer Medicine Consumption Share by Types in 2027

    • Table South China Prostate Cancer Medicine Consumption by End-Users from 2016 to 2027

    • Table South China Prostate Cancer Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure South China Prostate Cancer Medicine Consumption Share by End-Users in 2016

    • Figure South China Prostate Cancer Medicine Consumption Share by End-Users in 2021

    • Figure South China Prostate Cancer Medicine Consumption Share by End-Users in 2027

    • Table East China Prostate Cancer Medicine Consumption by Types from 2016 to 2027

    • Table East China Prostate Cancer Medicine Consumption Share by Types from 2016 to 2027

    • Figure East China Prostate Cancer Medicine Consumption Share by Types in 2016

    • Figure East China Prostate Cancer Medicine Consumption Share by Types in 2021

    • Figure East China Prostate Cancer Medicine Consumption Share by Types in 2027

    • Table East China Prostate Cancer Medicine Consumption by End-Users from 2016 to 2027

    • Table East China Prostate Cancer Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure East China Prostate Cancer Medicine Consumption Share by End-Users in 2016

    • Figure East China Prostate Cancer Medicine Consumption Share by End-Users in 2021

    • Figure East China Prostate Cancer Medicine Consumption Share by End-Users in 2027

    • Table Northeast China Prostate Cancer Medicine Consumption by Types from 2016 to 2027

    • Table Northeast China Prostate Cancer Medicine Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Prostate Cancer Medicine Consumption Share by Types in 2016

    • Figure Northeast China Prostate Cancer Medicine Consumption Share by Types in 2021

    • Figure Northeast China Prostate Cancer Medicine Consumption Share by Types in 2027

    • Table Northeast China Prostate Cancer Medicine Consumption by End-Users from 2016 to 2027

    • Table Northeast China Prostate Cancer Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Prostate Cancer Medicine Consumption Share by End-Users in 2016

    • Figure Northeast China Prostate Cancer Medicine Consumption Share by End-Users in 2021

    • Figure Northeast China Prostate Cancer Medicine Consumption Share by End-Users in 2027

    • Table Southwest China Prostate Cancer Medicine Consumption by Types from 2016 to 2027

    • Table Southwest China Prostate Cancer Medicine Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Prostate Cancer Medicine Consumption Share by Types in 2016

    • Figure Southwest China Prostate Cancer Medicine Consumption Share by Types in 2021

    • Figure Southwest China Prostate Cancer Medicine Consumption Share by Types in 2027

    • Table Southwest China Prostate Cancer Medicine Consumption by End-Users from 2016 to 2027

    • Table Southwest China Prostate Cancer Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Prostate Cancer Medicine Consumption Share by End-Users in 2016

    • Figure Southwest China Prostate Cancer Medicine Consumption Share by End-Users in 2021

    • Figure Southwest China Prostate Cancer Medicine Consumption Share by End-Users in 2027

    • Table Northwest China Prostate Cancer Medicine Consumption by Types from 2016 to 2027

    • Table Northwest China Prostate Cancer Medicine Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Prostate Cancer Medicine Consumption Share by Types in 2016

    • Figure Northwest China Prostate Cancer Medicine Consumption Share by Types in 2021

    • Figure Northwest China Prostate Cancer Medicine Consumption Share by Types in 2027

    • Table Northwest China Prostate Cancer Medicine Consumption by End-Users from 2016 to 2027

    • Table Northwest China Prostate Cancer Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Prostate Cancer Medicine Consumption Share by End-Users in 2016

    • Figure Northwest China Prostate Cancer Medicine Consumption Share by End-Users in 2021

    • Figure Northwest China Prostate Cancer Medicine Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Astellas Pharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc

    • Figure Sales and Growth Rate Analysis of Astellas Pharma Inc

    • Figure Revenue and Market Share Analysis of Astellas Pharma Inc

    • Table Product and Service Introduction of Astellas Pharma Inc

    • Table Company Profile and Development Status of Roche Holding AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Holding AG

    • Figure Sales and Growth Rate Analysis of Roche Holding AG

    • Figure Revenue and Market Share Analysis of Roche Holding AG

    • Table Product and Service Introduction of Roche Holding AG

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of Bristol Myers-Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol Myers-Squibb

    • Figure Sales and Growth Rate Analysis of Bristol Myers-Squibb

    • Figure Revenue and Market Share Analysis of Bristol Myers-Squibb

    • Table Product and Service Introduction of Bristol Myers-Squibb

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of AstraZeneca plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca plc

    • Figure Sales and Growth Rate Analysis of AstraZeneca plc

    • Figure Revenue and Market Share Analysis of AstraZeneca plc

    • Table Product and Service Introduction of AstraZeneca plc

    • Table Company Profile and Development Status of Teva Pharmaceuticals Industries Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceuticals Industries Ltd

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceuticals Industries Ltd

    • Figure Revenue and Market Share Analysis of Teva Pharmaceuticals Industries Ltd

    • Table Product and Service Introduction of Teva Pharmaceuticals Industries Ltd

    • Table Company Profile and Development Status of Active Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Active Biotech

    • Figure Sales and Growth Rate Analysis of Active Biotech

    • Figure Revenue and Market Share Analysis of Active Biotech

    • Table Product and Service Introduction of Active Biotech

    • Table Company Profile and Development Status of Bayer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

    • Figure Sales and Growth Rate Analysis of Bayer AG

    • Figure Revenue and Market Share Analysis of Bayer AG

    • Table Product and Service Introduction of Bayer AG


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US